(5-(苄氧基)-2-碘苯基)甲醇 | 50765-13-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: (5-(苄氧基)-2-碘苯基)甲醇
• 英文名称: (5-(benzyloxy)-2-iodophenyl)methanol
• 英文别名: (2-iodo-5-phenylmethoxyphenyl)methanol
• CAS: 50765-13-4
• 化学式: C₁₄H₁₃IO₂
• 分子量: 340.161
• InChiKey: CXSZODDHFZIYBY-UHFFFAOYSA-N

物化性质

• 沸点：
  438.5±40.0 °C(Predicted)
• 密度：
  1.619±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (5-(苄氧基)-2-碘苯基)甲醇 在 palladium diacetate 氯化亚砜 、 四丁基氯化铵 、 氢气 、 magnesium methanolate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 氯仿 为溶剂， 反应 26.5h， 生成 benzyl N-[(4S)-2-(2,2-dimethylpropyl)-3-oxo-8-phenylmethoxy-4,5-dihydro-1H-2-benzazepin-4-yl]carbamate
  参考文献：
  名称：

  Enantioselective synthesis of aminobenzazepinones

  摘要：

  Enantioselective synthesis of constrained trans-amino benzazepi none utilizing palladium-mediated Jeffery-Heck reaction and rhodium(II) catalyzed asymmetric hydrogenation as key steps are described. Diverse functional groups such as alkyl, aryl, basic or amino acid moieties were introduced with minimal racemization. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2007.02.078
• 作为产物：
  描述：

  5-羟基-2-碘苯甲醛 在 potassium carbonate 、 lithium tri-t-butoxyaluminum hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 (5-(苄氧基)-2-碘苯基)甲醇
  参考文献：
  名称：

  潜在的器官或肿瘤显像剂。11.放射性碘化酪胺。

  摘要：

  DOI：

  10.1021/jm00264a023

文献信息

• Palladium-catalyzed intermolecular tandem cyclization reaction: a highly regioselective synthesis of functionalized 3H-spiro[isobenzofuran-1,3′-isochroman] scaffolds
  作者：Liang Wang、Xuehu Li、Hua Tao、Xiang Zhou、Xihong Lu、Wenyue Du、Tingting Jiang、Zhijun Xin、Jianping Liang

  DOI：10.1039/c6ob02802k

  日期：——

  functionalized 3H-spiro[isobenzofuran-1,3′-isochroman] scaffolds using a novel palladium-catalyzed tandem cyclization reaction is explored. During the reaction process, C–O, C–C and C–O bonds are sequentially formed in one pot via decarboxylative allenylpalladium formation, nucleophilic attack, arylpalladium addition and intramolecular nucleophilic attack.

  探索了使用新型钯催化串联环化反应的功能性3 H-螺[异苯并呋喃-1,3'-异色满]支架的高度区域选择性合成。在反应过程中，通过脱羧化烯基钯的形成，亲核攻击，芳基钯加成和分子内亲核攻击，在一个罐中依次形成C–O ，CC和C–O键。
• Constrained compounds as CGRP-receptor antagonists
  申请人：Chaturvedula V. Prasad

  公开号：US20060094707A1

  公开（公告）日：2006-05-04

  The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

  这项发明涵盖了受限的双环和三环CGRP受体拮抗剂，用于识别它们的方法，包含它们的药物组合物，以及它们在治疗偏头痛和其他头痛、神经源性血管舒张、神经源性炎症、热损伤、循环性休克、与绝经期相关的潮红、气道炎症性疾病（如哮喘和慢性阻塞性肺病（COPD））以及其他可以通过CGRP受体拮抗来治疗的疾病的治疗方法。
• CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS
  申请人：Chaturvedula Prasad V.

  公开号：US20070259851A1

  公开（公告）日：2007-11-08

  The invention encompasses constrained bicyclic and tricyclic CGRP-receptor antagonists, methods for identifying them, pharmaceutical compositions comprising them, and methods for their use in therapy for treatment of migraine and other headaches, neurogenic vasodilation, neurogenic inflammation, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.

  本发明包括受约束的双环和三环CGRP受体拮抗剂，识别它们的方法，包含它们的药物组合物，以及它们在治疗偏头痛和其他头痛、神经源性血管扩张、神经性炎症、热损伤、循环性休克、与更年期相关的潮红、气道炎症性疾病（如哮喘和慢性阻塞性肺病（COPD））中的用途，以及其他可以通过CGRP受体拮抗剂治疗的疾病。
• Synthesis and antifungal properties of papulacandin derivatives
  作者：Marjolein van der Kaaden、Eefjan Breukink、Roland J Pieters

  DOI：10.3762/bjoc.8.82

  日期：——

  Derivatives of an antifungal agent that targets the β-(1,3)-D-glucan synthase, papulacandin D, were synthesized and tested for activity. The papulacandin D structure contains a challenging benzannulated spiroketal unit, which is introduced in a palladium-catalyzed cross-coupling reaction of a glycal silanolate and an aryl iodide followed by an oxidative spiroketalization. Four different variants were made, differing in the nature of the acyl side chain with respect to the length, and in the number and stereochemistry of the double bonds. Moderate biological activity was observed for the derivatives with a side chain based on palmitic acid and linoleic acid.

  一种靶向β-(1,3)-D-葡聚糖合酶的抗真菌剂 papulacandin D 的衍生物已合成并进行了活性测试。papulacandin D 结构包含一个具有挑战性的苯环螺环糖醚单元，该单元是通过一种钯催化的糖环硅醇酸酯和芳基碘化物的交叉偶联反应引入的，随后进行氧化螺环糖醚化反应。制备了四种不同的变体，其在酰基侧链的性质、长度以及双键的数量和立体化学方面有所不同。基于棕榈酸和亚油酸的侧链的衍生物显示出中等生物活性。
• Concise Stereoselective Synthesis of Oxaspirocycles with 1-Tosyl-1,2,3-triazoles: Application to the Total Syntheses of (±)-Tuberostemospiroline and (±)-Stemona-lactam R
  作者：Junkai Fu、Hongjuan Shen、Yuanyuan Chang、Chuangchuang Li、Jianxian Gong、Zhen Yang

  DOI：10.1002/chem.201403756

  日期：2014.9.26

  A 4‐substituted‐1‐tosyl‐1,2,3‐triazole‐based stereoselective synthesis of structurally diverse oxaspirocycles is reported. The synthesis involves Rh‐catalyzed loss of nitrogen from 4‐substituted‐1‐tosyl‐1,2,3‐triazoles, Grignard reaction, and a ring‐closing metathesis reaction as key steps. By employing readily available and stable 4‐substituted‐1‐tosyl‐1,2,3‐triazoles as surrogates of diazo compounds

  据报道，基于4-取代-1，对甲苯基1,2,3-三唑的立体选择性合成结构多样的oxaspirocycles。合成涉及关键步骤，其中包括Rh催化的4-取代-1-甲苯磺酰基1,2,3-三唑的氮损失，格氏反应和闭环易位反应。通过使用现成的，稳定的4-取代-1-甲苯磺酰基1,2,3-三唑作为重氮化合物和氮源的替代物，获得了两种类型的氧杂螺环。后者含有相邻的氮立体中心，可以作为许多天然产物的核心结构。该化学方法已成功应用于（±）-溴代螺螺啉和（±）-stemona-lactam R的全部合成中。